High incidence of discontinuations due to adverse events in patients treated with ceftaroline.

Abstract

STUDY OBJECTIVE To determine clinical outcomes in patients who received ceftaroline (Teflaro) 600 mg intravenously every 8 or 12 hours after failing or developing intolerance to first-line agents including vancomycin, daptomycin, or linezolid. DESIGN Retrospective chart review and review of the literature. SETTING Large academic medical center and… (More)
DOI: 10.1002/phar.1435

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics